1. Home
  2. CDNA vs REAX Comparison

CDNA vs REAX Comparison

Compare CDNA & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • REAX
  • Stock Information
  • Founded
  • CDNA 1998
  • REAX 2018
  • Country
  • CDNA United States
  • REAX United States
  • Employees
  • CDNA N/A
  • REAX N/A
  • Industry
  • CDNA Medical Specialities
  • REAX
  • Sector
  • CDNA Health Care
  • REAX
  • Exchange
  • CDNA Nasdaq
  • REAX Nasdaq
  • Market Cap
  • CDNA 712.2M
  • REAX 800.1M
  • IPO Year
  • CDNA 2014
  • REAX N/A
  • Fundamental
  • Price
  • CDNA $11.84
  • REAX $4.49
  • Analyst Decision
  • CDNA Buy
  • REAX Strong Buy
  • Analyst Count
  • CDNA 6
  • REAX 3
  • Target Price
  • CDNA $27.67
  • REAX $6.33
  • AVG Volume (30 Days)
  • CDNA 1.5M
  • REAX 1.3M
  • Earning Date
  • CDNA 08-06-2025
  • REAX 08-07-2025
  • Dividend Yield
  • CDNA N/A
  • REAX N/A
  • EPS Growth
  • CDNA N/A
  • REAX N/A
  • EPS
  • CDNA 1.00
  • REAX N/A
  • Revenue
  • CDNA $340,826,000.00
  • REAX $1,617,846,000.00
  • Revenue This Year
  • CDNA $12.81
  • REAX $44.55
  • Revenue Next Year
  • CDNA $13.36
  • REAX $16.68
  • P/E Ratio
  • CDNA $11.87
  • REAX N/A
  • Revenue Growth
  • CDNA 14.72
  • REAX 72.57
  • 52 Week Low
  • CDNA $10.96
  • REAX $3.80
  • 52 Week High
  • CDNA $34.84
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 33.98
  • REAX 62.72
  • Support Level
  • CDNA $11.73
  • REAX $3.87
  • Resistance Level
  • CDNA $12.76
  • REAX $4.58
  • Average True Range (ATR)
  • CDNA 0.64
  • REAX 0.21
  • MACD
  • CDNA 0.13
  • REAX 0.06
  • Stochastic Oscillator
  • CDNA 28.61
  • REAX 87.41

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: